Johnson & Johnson Pledges $1 Billion to Fight COVID-19
Make no mistake, PR considerations are going into some of these decisions by “Big Pharma”…
Make no mistake, PR considerations are going into some of these decisions by “Big Pharma”…
The design is for point-of-care facilities like doctors’ offices, emergency rooms, and urgent care clinics…
The team also assumed that COVID-19 first reached the U.K. by mid-January, which is a conservative assumption...
Markets will need a few things to happen in order to see the recovery that is coming…
These numbers are beyond crazy. And it’s all because people are staying home...
If we can find a compound that proactively binds to COVID-19, the virus won’t be able to bind to...
They hope to advance a therapy into FDA clinical trials this summer…
Moderna got FDA permission to skip the animal trials that are typically required before a therapy can be tested...
One of the most challenging tasks humanity will face over the next few years is to use bleeding-edge technology...